Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)

<p>Abstract</p> <p>Background</p> <p>The changes in the liver in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However it has remained difficult to differentiate between NASH and non-progressive...

Full description

Bibliographic Details
Main Authors: Saito Satoru, Kubota Kensuke, Kobayashi Noritoshi, Nozaki Yuichi, Inamori Masahiko, Kirikoshi Hiroyuki, Takahashi Hirokazu, Iida Hiroshi, Mawatari Hironori, Yoneda Kyoko, Fujita Koji, Endo Hiroki, Kato Shingo, Uchiyama Takashi, Yoneda Masato, Maeyama Shiro, Sagara Mina, Aburatani Hiroyuki, Kodama Tatsuhiko, Nakajima Atsushi
Format: Article
Language:English
Published: BMC 2008-11-01
Series:BMC Gastroenterology
Online Access:http://www.biomedcentral.com/1471-230X/8/53